TNON (Tenon Medical) Moat Score: 4/10 (As of Jul. 05, 2026)


TNON Tenon Medical Inc TNON
42 GF Score
Price $0.29
GF Value $0.35
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Tenon Medical Moat Score?

Tenon Medical TNON -10.39% 42 Moat Score is 4 as of Jul. 05, 2026. GuruFocus rates TNON with a GF Score™ of 42/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Tenon Medical ranks better than 83.31% on this metric.

Tenon Medical has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Tenon Medical has Narrow Moat: Tenon Medical Inc has a discernible but modest moat due to its specialized medical devices and some intellectual property. However, the market is competitive, and the company's pricing power and brand strength are limited.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tenon Medical might have Narrow Moat - Discernible but modest moat.

Tenon Medical  (NAS:TNON) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tenon Medical Moat Score Related Terms

TNON vs XAIR, VVOS, BMRA: Moat Score Comparison

For the Medical Devices subindustry, Tenon Medical's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tenon Medical Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's Moat Score distribution charts can be found below:

* The bar in red indicates where Tenon Medical's Moat Score falls into.


TNON
42GF Score
Tenon Medical Inc TNON
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Tenon Medical (TNON) has a Moat Score of 4 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Tenon Medical ranks #141 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Tenon Medical's Moat Score too high?
Tenon Medical's current Moat Score is 4. Based on the distribution chart, Tenon Medical ranks #141 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Tenon Medical has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's Moat Score compare to XAIR and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Tenon Medical ranks #141 out of 845 companies for Moat Score. This places Tenon Medical in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Tenon Medical's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current Moat Score is 4. Tenon Medical's overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Tenon Medical (TNON), the current Moat Score is 4 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenon Medical (TNON) Overvalued in 2026?

Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued. The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35. GuruFocus considers Tenon Medical to be Modestly Undervalued.

Key valuation signals for TNON:

  • Moat Score: 4
  • GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tenon Medical Business Description

Address 104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
42GF Score

Get the complete analysis for TNON

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price
$0.35
GF Value